Redefine Patient Care
Is your practice leading the way with innovative treatment options?
Tackle Pain and Aesthetic Concerns FAST
Learn about non-surgical, low-risk treatment options that allow you to stay active.
Set your practice apart by offering the regenerative solutions your patients are seeking.
The FDA Approved Focused Shockwave is the next generation of ESWT Extracorporeal Shock Wave Treatment with patented focused “Cylindrical Source“ Technology available from CuraMedix. This unique device leads the industry in innovation and performance for the treatment of pain associated with chronic proximal plantar fasciitis.
With its progressive technological advancements, Extracorporeal Pulse Activation Technology (EPAT/ESWT) delivers an evidence-based*, non-surgical solution for patients suffering from chronic heel pain.
It addresses the increasing demand for patient convenience, less down-time and risk, as well as better clinical and economic outcomes, and improved practice efficiencies and cash-flow.
Health care professionals are using ESWT to successfully treat acute or chronic musculoskeletal pain and/or
Check out the study published in The Journal of Bone Joint Surgery “Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study.”
The best way to advance patient care for your practice is looking to the evidence that’s available for new technologies and protocols. CuraMedix solutions like AWT are backed by clinical studies and are evidence-based; whereas similar competing technologies cannot make this claim.